APO Research
Talk to an analyst

APO RESEARCH · REPORT

Gamma Delta T Cell Cancer Therapy

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Gamma Delta T Cell Cancer Therapy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

2 January 2026172 pages

Choose your research edition.

Industry ResearchGamma Delta T Cell Cancer Therapy Industry Research Report 2026101 pages · $2,950 USDIndustry Growth & TrendsGlobal Gamma Delta T Cell Cancer Therapy Industry Growth and Trends Forecast to 203261 pages · $3,450 USDMarket StructureGlobal Gamma Delta T Cell Cancer Therapy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032172 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gamma Delta T Cell Cancer Therapy Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Gamma Delta T Cell Cancer Therapy Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Gamma Delta T Cell Cancer Therapy market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Gamma Delta T Cell Cancer Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Gamma Delta T Cell Cancer Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Gamma Delta T Cell Cancer Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Gamma Delta T Cell Cancer Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Gamma Delta T Cell Cancer Therapy include Takeda Pharma, TC Biopharma, Adapate Therapeutics and Acopedia, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Gamma Delta T Cell Cancer Therapy market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Gamma Delta T Cell Cancer Therapy and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Gamma Delta T Cell Cancer Therapy revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Gamma Delta T Cell Cancer Therapy market size, projected growth trends, production technologies, key applications, and end-use industries.

Gamma Delta T Cell Cancer Therapy Segment by Company

Takeda Pharma

TC Biopharma

Adapate Therapeutics

Acopedia

Gamma Delta T Cell Cancer Therapy Segment by Type

Targeted Therapy

Chemotherapy

Biology

Other

Gamma Delta T Cell Cancer Therapy Segment by Application

Clinical

Experiment

Gamma Delta T Cell Cancer Therapy Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gamma Delta T Cell Cancer Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gamma Delta T Cell Cancer Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gamma Delta T Cell Cancer Therapy.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Gamma Delta T Cell Cancer Therapy in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Gamma Delta T Cell Cancer Therapy industry.

Chapter 3: Detailed analysis of Gamma Delta T Cell Cancer Therapy companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Gamma Delta T Cell Cancer Therapyrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Gamma Delta T Cell Cancer Therapy Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Targeted Therapy Table 3. Key Players of Chemotherapy Table 4. Key Players of Biology Table 3. Key Players of Other Table 4. Global Gamma Delta T Cell Cancer Therapy Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Clinical Table 6. Key Players of Experiment Table 7. Global Gamma Delta T Cell Cancer Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 8. Global Gamma Delta T Cell Cancer Therapy Market Size by Region (2021-2026) & (US$ Million) Table 9. Global Gamma Delta T Cell Cancer Therapy Market Share by Region (2021-2026) Table 10. Global Gamma Delta T Cell Cancer Therapy Market Size by Region (2027-2032) & (US$ Million) Table 11. Global Gamma Delta T Cell Cancer Therapy Market Share by Region (2027-2032) Table 12. Gamma Delta T Cell Cancer Therapy Industry Trends Table 13. Gamma Delta T Cell Cancer Therapy Industry Drivers Table 14. Gamma Delta T Cell Cancer Therapy Industry Opportunities and Challenges Table 15. Gamma Delta T Cell Cancer Therapy Industry Restraints Table 16. Global Gamma Delta T Cell Cancer Therapy Revenue by Company (US$ Million) & (2021-2026) Table 17. Global Gamma Delta T Cell Cancer Therapy Revenue Market Share by Company (2021-2026) Table 18. Global Gamma Delta T Cell Cancer Therapy Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 19. Global Gamma Delta T Cell Cancer Therapy Key Company Head Office and Area Served Table 20. Global Gamma Delta T Cell Cancer Therapy Company, Product Type & Application Table 21. Global Gamma Delta T Cell Cancer Therapy Company Establishment Date Table 22. Global Company Market Concentration Ratio (CR5 and HHI) Table 23. Global Gamma Delta T Cell Cancer Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 24. Global Gamma Delta T Cell Cancer Therapy Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Gamma Delta T Cell Cancer Therapy Market Size by Type (2021-2026) & (US$ Million) Table 26. Global Gamma Delta T Cell Cancer Therapy Market Size by Type (2027-2032) & (US$ Million) Table 27. Global Gamma Delta T Cell Cancer Therapy Revenue Market Share by Type (2021-2026) Table 28. Global Gamma Delta T Cell Cancer Therapy Revenue Market Share by Type (2027-2032) Table 29. Global Gamma Delta T Cell Cancer Therapy Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Gamma Delta T Cell Cancer Therapy Market Size by Application (2021-2026) & (US$ Million) Table 31. Global Gamma Delta T Cell Cancer Therapy Market Size by Application (2027-2032) & (US$ Million) Table 32. Global Gamma Delta T Cell Cancer Therapy Revenue Market Share by Application (2021-2026) Table 33. Global Gamma Delta T Cell Cancer Therapy Revenue Market Share by Application (2027-2032) Table 34. Takeda Pharma Company Information Table 35. Takeda Pharma Business Overview Table 36. Takeda Pharma Gamma Delta T Cell Cancer Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. Takeda Pharma Gamma Delta T Cell Cancer Therapy Product Portfolio Table 38. Takeda Pharma Recent Development Table 39. TC Biopharma Company Information Table 40. TC Biopharma Business Overview Table 41. TC Biopharma Gamma Delta T Cell Cancer Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. TC Biopharma Gamma Delta T Cell Cancer Therapy Product Portfolio Table 43. TC Biopharma Recent Development Table 44. Adapate Therapeutics Company Information Table 45. Adapate Therapeutics Business Overview Table 46. Adapate Therapeutics Gamma Delta T Cell Cancer Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Adapate Therapeutics Gamma Delta T Cell Cancer Therapy Product Portfolio Table 48. Adapate Therapeutics Recent Development Table 49. Acopedia Company Information Table 50. Acopedia Business Overview Table 51. Acopedia Gamma Delta T Cell Cancer Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Acopedia Gamma Delta T Cell Cancer Therapy Product Portfolio Table 53. Acopedia Recent Development Table 54. North America Gamma Delta T Cell Cancer Therapy Market Size by Type (2021-2026) & (US$ Million) Table 55. North America Gamma Delta T Cell Cancer Therapy Market Size by Type (2027-2032) & (US$ Million) Table 56. North America Gamma Delta T Cell Cancer Therapy Market Size by Application (2021-2026) & (US$ Million) Table 57. North America Gamma Delta T Cell Cancer Therapy Market Size by Application (2027-2032) & (US$ Million) Table 58. North America Gamma Delta T Cell Cancer Therapy Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 59. North America Gamma Delta T Cell Cancer Therapy Market Size by Country (2021-2026) Table 60. North America Gamma Delta T Cell Cancer Therapy Market Size by Country (2027-2032) Table 61. Europe Gamma Delta T Cell Cancer Therapy Market Size by Type (2021-2026) & (US$ Million) Table 62. Europe Gamma Delta T Cell Cancer Therapy Market Size by Type (2027-2032) & (US$ Million) Table 63. Europe Gamma Delta T Cell Cancer Therapy Market Size by Application (2021-2026) & (US$ Million) Table 64. Europe Gamma Delta T Cell Cancer Therapy Market Size by Application (2027-2032) & (US$ Million) Table 65. Europe Gamma Delta T Cell Cancer Therapy Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 66. Europe Gamma Delta T Cell Cancer Therapy Market Size by Country (2021-2026) Table 67. Europe Gamma Delta T Cell Cancer Therapy Market Size by Country (2027-2032) Table 68. China Gamma Delta T Cell Cancer Therapy Market Size by Type (2021-2026) & (US$ Million) Table 69. China Gamma Delta T Cell Cancer Therapy Market Size by Type (2027-2032) & (US$ Million) Table 70. China Gamma Delta T Cell Cancer Therapy Market Size by Application (2021-2026) & (US$ Million) Table 71. China Gamma Delta T Cell Cancer Therapy Market Size by Application (2027-2032) & (US$ Million) Table 72. Asia Gamma Delta T Cell Cancer Therapy Market Size by Type (2021-2026) & (US$ Million) Table 73. Asia Gamma Delta T Cell Cancer Therapy Market Size by Type (2027-2032) & (US$ Million) Table 74. Asia Gamma Delta T Cell Cancer Therapy Market Size by Application (2021-2026) & (US$ Million) Table 75. Asia Gamma Delta T Cell Cancer Therapy Market Size by Application (2027-2032) & (US$ Million) Table 76. Asia Gamma Delta T Cell Cancer Therapy Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 77. Asia Gamma Delta T Cell Cancer Therapy Market Size by Country (2021-2026) Table 78. Asia Gamma Delta T Cell Cancer Therapy Market Size by Country (2027-2032) Table 79. South America, Middle East & Africa Gamma Delta T Cell Cancer Therapy Market Size by Type (2021-2026) & (US$ Million) Table 80. South America, Middle East & Africa Gamma Delta T Cell Cancer Therapy Market Size by Type (2027-2032) & (US$ Million) Table 81. South America, Middle East & Africa Gamma Delta T Cell Cancer Therapy Market Size by Application (2021-2026) & (US$ Million) Table 82. South America, Middle East & Africa Gamma Delta T Cell Cancer Therapy Market Size by Application (2027-2032) & (US$ Million) Table 83. South America, Middle East & Africa Gamma Delta T Cell Cancer Therapy Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 84. South America, Middle East & Africa Gamma Delta T Cell Cancer Therapy Market Size by Country (2021-2026) Table 85. South America, Middle East & Africa Gamma Delta T Cell Cancer Therapy Market Size by Country (2027-2032) Table 86. Research Programs/Design for This Report Table 87. Authors List of This Report Table 88. Secondary Sources Table 89. Primary Sources List of Figures Figure 1. Gamma Delta T Cell Cancer Therapy Product Image Figure 2. Global Gamma Delta T Cell Cancer Therapy Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Gamma Delta T Cell Cancer Therapy Market Share by Type: 2025 VS 2032 Figure 4. Targeted Therapy Image Figure 5. Chemotherapy Image Figure 6. Biology Image Figure 7. Other Image Figure 8. Global Gamma Delta T Cell Cancer Therapy Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global Gamma Delta T Cell Cancer Therapy Market Share by Application: 2025 VS 2032 Figure 10. Clinical Image Figure 11. Experiment Image Figure 12. Global Gamma Delta T Cell Cancer Therapy Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Gamma Delta T Cell Cancer Therapy Market Size (2021-2032) & (US$ Million) Figure 14. Global Gamma Delta T Cell Cancer Therapy Market Share by Region: 2025 VS 2032 Figure 15. Years Considered Figure 16. Global Gamma Delta T Cell Cancer Therapy Market Share by Players in 2025 Figure 17. Global Top 5 and 10 Gamma Delta T Cell Cancer Therapy Players Market Share by Revenue in 2025 Figure 18. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Gamma Delta T Cell Cancer Therapy Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Gamma Delta T Cell Cancer Therapy Revenue Market Share by Type (2021-2032) Figure 21. Global Gamma Delta T Cell Cancer Therapy Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Gamma Delta T Cell Cancer Therapy Revenue Market Share by Application (2021-2032) Figure 23. North America Gamma Delta T Cell Cancer Therapy Market Size (2021-2032) & (US$ Million) Figure 24. North America Gamma Delta T Cell Cancer Therapy Market Share by Type (2021-2032) Figure 25. North America Gamma Delta T Cell Cancer Therapy Market Share by Application (2021-2032) Figure 26. North America Gamma Delta T Cell Cancer Therapy Market Share by Country (2021-2032) Figure 27. United States Gamma Delta T Cell Cancer Therapy Market Size (2021-2032) & (US$ Million) Figure 28. Canada Gamma Delta T Cell Cancer Therapy Market Size (2021-2032) & (US$ Million) Figure 29. Mexico Gamma Delta T Cell Cancer Therapy Market Size (2021-2032) & (US$ Million) Figure 30. Europe Gamma Delta T Cell Cancer Therapy Market Size (2021-2032) & (US$ Million) Figure 31. Europe Gamma Delta T Cell Cancer Therapy Market Share by Type (2021-2032) Figure 32. Europe Gamma Delta T Cell Cancer Therapy Market Share by Application (2021-2032) Figure 33. Europe Gamma Delta T Cell Cancer Therapy Market Share by Country (2021-2032) Figure 34. Germany Gamma Delta T Cell Cancer Therapy Market Size (2021-2032) & (US$ Million) Figure 35. France Gamma Delta T Cell Cancer Therapy Market Size (2021-2032) & (US$ Million) Figure 36. U.K. Gamma Delta T Cell Cancer Therapy Market Size (2021-2032) & (US$ Million) Figure 37. Italy Gamma Delta T Cell Cancer Therapy Market Size (2021-2032) & (US$ Million) Figure 38. Russia Gamma Delta T Cell Cancer Therapy Market Size (2021-2032) & (US$ Million) Figure 39. Nordic Countries Gamma Delta T Cell Cancer Therapy Market Size (2021-2032) & (US$ Million) Figure 40. China Gamma Delta T Cell Cancer Therapy Market Size (2021-2032) & (US$ Million) Figure 41. China Gamma Delta T Cell Cancer Therapy Market Share by Type (2021-2032) Figure 42. China Gamma Delta T Cell Cancer Therapy Market Share by Application (2021-2032) Figure 43. Asia Gamma Delta T Cell Cancer Therapy Market Size (2021-2032) & (US$ Million) Figure 44. Asia Gamma Delta T Cell Cancer Therapy Market Share by Type (2021-2032) Figure 45. Asia Gamma Delta T Cell Cancer Therapy Market Share by Application (2021-2032) Figure 46. Asia Gamma Delta T Cell Cancer Therapy Market Share by Country (2021-2032) Figure 47. Japan Gamma Delta T Cell Cancer Therapy Market Size (2021-2032) & (US$ Million) Figure 48. South Korea Gamma Delta T Cell Cancer Therapy Market Size (2021-2032) & (US$ Million) Figure 49. Taiwan Gamma Delta T Cell Cancer Therapy Market Size (2021-2032) & (US$ Million) Figure 50. Southeast Asia Gamma Delta T Cell Cancer Therapy Market Size (2021-2032) & (US$ Million) Figure 51. India Gamma Delta T Cell Cancer Therapy Market Size (2021-2032) & (US$ Million) Figure 52. Australia Gamma Delta T Cell Cancer Therapy Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Gamma Delta T Cell Cancer Therapy Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Gamma Delta T Cell Cancer Therapy Market Share by Type (2021-2032) Figure 55. South America, Middle East & Africa Gamma Delta T Cell Cancer Therapy Market Share by Application (2021-2032) Figure 56. South America, Middle East & Africa Gamma Delta T Cell Cancer Therapy Market Share by Country (2021-2032) Figure 57. Brazil Gamma Delta T Cell Cancer Therapy Market Size (2021-2032) & (US$ Million) Figure 58. South Africa Gamma Delta T Cell Cancer Therapy Market Size (2021-2032) & (US$ Million) Figure 59. Saudi Arabia Gamma Delta T Cell Cancer Therapy Market Size (2021-2032) & (US$ Million) Figure 60. Turkey Gamma Delta T Cell Cancer Therapy Market Size (2021-2032) & (US$ Million) Figure 61. Argentina Gamma Delta T Cell Cancer Therapy Market Size (2021-2032) & (US$ Million) Figure 62. UAE Gamma Delta T Cell Cancer Therapy Market Size (2021-2032) & (US$ Million) Figure 63. Egypt Gamma Delta T Cell Cancer Therapy Market Size (2021-2032) & (US$ Million) Figure 64. Chile Gamma Delta T Cell Cancer Therapy Market Size (2021-2032) & (US$ Million) Figure 65. Research Process Figure 66. Key Executives Interviewed

Scope & coverage.

Types
  • Targeted Therapy
  • Chemotherapy
  • Biology
  • Other
Applications
  • Clinical
  • Experiment
Companies covered
  • Takeda Pharma
  • TC Biopharma
  • Adapate Therapeutics
  • Acopedia

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Gamma Delta T Cell Cancer Therapy Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Targeted Therapy
  5. 1.2.3 Chemotherapy
  6. 1.2.4 Biology
  7. 1.2.5 Other
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global Gamma Delta T Cell Cancer Therapy Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Clinical
  11. 1.3.3 Experiment
  12. 1.4 Global Market Growth Prospects
  13. 1.5 Global Gamma Delta T Cell Cancer Therapy Growth Trends by Region
  14. 1.5.1 Global Gamma Delta T Cell Cancer Therapy Market Size by Region: 2021 VS 2025 VS 2032
  15. 1.5.2 Gamma Delta T Cell Cancer Therapy Market Size by Region (2021-2026)
  16. 1.5.3 Gamma Delta T Cell Cancer Therapy Market Size by Region (2027-2032)
  17. 1.6 Assumptions and Limitations
  18. 1.7 Study Goals and Objectives
  19. 1.8 Years Considered
2 Global Gamma Delta T Cell Cancer Therapy Market Dynamics
  1. 2.1 Gamma Delta T Cell Cancer Therapy Industry Trends
  2. 2.2 Gamma Delta T Cell Cancer Therapy Industry Drivers
  3. 2.3 Gamma Delta T Cell Cancer Therapy Industry Opportunities and Challenges
  4. 2.4 Gamma Delta T Cell Cancer Therapy Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Gamma Delta T Cell Cancer Therapy Revenue by Company (2021-2026)
  2. 3.2 Global Gamma Delta T Cell Cancer Therapy Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Gamma Delta T Cell Cancer Therapy Key Company Head office and Area Served
  4. 3.4 Global Gamma Delta T Cell Cancer Therapy Company, Product Type & Application
  5. 3.5 Global Gamma Delta T Cell Cancer Therapy Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Gamma Delta T Cell Cancer Therapy Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Gamma Delta T Cell Cancer Therapy Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Gamma Delta T Cell Cancer Therapy Tier 1, Tier 2, and Tier 3
4 Gamma Delta T Cell Cancer Therapy Market by Type
  1. 4.1 Global Gamma Delta T Cell Cancer Therapy Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Gamma Delta T Cell Cancer Therapy Market Size by Type (2021-2032)
  3. 4.3 Global Gamma Delta T Cell Cancer Therapy Market Size Share by Type (2021-2032)
5 Gamma Delta T Cell Cancer Therapy Market by Application
  1. 5.1 Global Gamma Delta T Cell Cancer Therapy Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Gamma Delta T Cell Cancer Therapy Market Size by Application (2021-2032)
  3. 5.3 Global Gamma Delta T Cell Cancer Therapy Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Takeda Pharma
  2. 6.1.1 Takeda Pharma Company Information
  3. 6.1.2 Takeda Pharma Business Overview
  4. 6.1.3 Takeda Pharma Gamma Delta T Cell Cancer Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Takeda Pharma Gamma Delta T Cell Cancer Therapy Product Portfolio
  6. 6.1.5 Takeda Pharma Recent Developments
  7. 6.2 TC Biopharma
  8. 6.2.1 TC Biopharma Company Information
  9. 6.2.2 TC Biopharma Business Overview
  10. 6.2.3 TC Biopharma Gamma Delta T Cell Cancer Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 TC Biopharma Gamma Delta T Cell Cancer Therapy Product Portfolio
  12. 6.2.5 TC Biopharma Recent Developments
  13. 6.3 Adapate Therapeutics
  14. 6.3.1 Adapate Therapeutics Company Information
  15. 6.3.2 Adapate Therapeutics Business Overview
  16. 6.3.3 Adapate Therapeutics Gamma Delta T Cell Cancer Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Adapate Therapeutics Gamma Delta T Cell Cancer Therapy Product Portfolio
  18. 6.3.5 Adapate Therapeutics Recent Developments
  19. 6.4 Acopedia
  20. 6.4.1 Acopedia Company Information
  21. 6.4.2 Acopedia Business Overview
  22. 6.4.3 Acopedia Gamma Delta T Cell Cancer Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Acopedia Gamma Delta T Cell Cancer Therapy Product Portfolio
  24. 6.4.5 Acopedia Recent Developments
7 North America
  1. 7.1 North America Gamma Delta T Cell Cancer Therapy Market Size (2021-2032)
  2. 7.2 North America Gamma Delta T Cell Cancer Therapy Market Size by Type
  3. 7.2.1 North America Gamma Delta T Cell Cancer Therapy Market Size by Type (2021-2026)
  4. 7.2.2 North America Gamma Delta T Cell Cancer Therapy Market Size by Type (2027-2032)
  5. 7.2.3 North America Gamma Delta T Cell Cancer Therapy Market Share by Type (2021-2032)
  6. 7.3 North America Gamma Delta T Cell Cancer Therapy Market Size by Application
  7. 7.3.1 North America Gamma Delta T Cell Cancer Therapy Market Size by Application (2021-2026)
  8. 7.3.2 North America Gamma Delta T Cell Cancer Therapy Market Size by Application (2027-2032)
  9. 7.3.3 North America Gamma Delta T Cell Cancer Therapy Market Share by Application (2021-2032)
  10. 7.4 North America Gamma Delta T Cell Cancer Therapy Market Size by Country
  11. 7.4.1 North America Gamma Delta T Cell Cancer Therapy Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Gamma Delta T Cell Cancer Therapy Market Size by Country (2021-2026)
  13. 7.4.3 North America Gamma Delta T Cell Cancer Therapy Market Size by Country (2027-2032)
  14. 7.4.4 North America Gamma Delta T Cell Cancer Therapy Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Gamma Delta T Cell Cancer Therapy Market Size (2021-2032)
  2. 8.2 Europe Gamma Delta T Cell Cancer Therapy Market Size by Type
  3. 8.2.1 Europe Gamma Delta T Cell Cancer Therapy Market Size by Type (2021-2026)
  4. 8.2.2 Europe Gamma Delta T Cell Cancer Therapy Market Size by Type (2027-2032)
  5. 8.2.3 Europe Gamma Delta T Cell Cancer Therapy Market Share by Type (2021-2032)
  6. 8.3 Europe Gamma Delta T Cell Cancer Therapy Market Size by Application
  7. 8.3.1 Europe Gamma Delta T Cell Cancer Therapy Market Size by Application (2021-2026)
  8. 8.3.2 Europe Gamma Delta T Cell Cancer Therapy Market Size by Application (2027-2032)
  9. 8.3.3 Europe Gamma Delta T Cell Cancer Therapy Market Share by Application (2021-2032)
  10. 8.4 Europe Gamma Delta T Cell Cancer Therapy Market Size by Country
  11. 8.4.1 Europe Gamma Delta T Cell Cancer Therapy Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Gamma Delta T Cell Cancer Therapy Market Size by Country (2021-2026)
  13. 8.4.3 Europe Gamma Delta T Cell Cancer Therapy Market Size by Country (2027-2032)
  14. 8.4.4 Europe Gamma Delta T Cell Cancer Therapy Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Gamma Delta T Cell Cancer Therapy Market Size (2021-2032)
  2. 9.2 China Gamma Delta T Cell Cancer Therapy Market Size by Type
  3. 9.2.1 China Gamma Delta T Cell Cancer Therapy Market Size by Type (2021-2026)
  4. 9.2.2 China Gamma Delta T Cell Cancer Therapy Market Size by Type (2027-2032)
  5. 9.2.3 China Gamma Delta T Cell Cancer Therapy Market Share by Type (2021-2032)
  6. 9.3 China Gamma Delta T Cell Cancer Therapy Market Size by Application
  7. 9.3.1 China Gamma Delta T Cell Cancer Therapy Market Size by Application (2021-2026)
  8. 9.3.2 China Gamma Delta T Cell Cancer Therapy Market Size by Application (2027-2032)
  9. 9.3.3 China Gamma Delta T Cell Cancer Therapy Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Gamma Delta T Cell Cancer Therapy Market Size (2021-2032)
  2. 10.2 Asia Gamma Delta T Cell Cancer Therapy Market Size by Type
  3. 10.2.1 Asia Gamma Delta T Cell Cancer Therapy Market Size by Type (2021-2026)
  4. 10.2.2 Asia Gamma Delta T Cell Cancer Therapy Market Size by Type (2027-2032)
  5. 10.2.3 Asia Gamma Delta T Cell Cancer Therapy Market Share by Type (2021-2032)
  6. 10.3 Asia Gamma Delta T Cell Cancer Therapy Market Size by Application
  7. 10.3.1 Asia Gamma Delta T Cell Cancer Therapy Market Size by Application (2021-2026)
  8. 10.3.2 Asia Gamma Delta T Cell Cancer Therapy Market Size by Application (2027-2032)
  9. 10.3.3 Asia Gamma Delta T Cell Cancer Therapy Market Share by Application (2021-2032)
  10. 10.4 Asia Gamma Delta T Cell Cancer Therapy Market Size by Country
  11. 10.4.1 Asia Gamma Delta T Cell Cancer Therapy Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Gamma Delta T Cell Cancer Therapy Market Size by Country (2021-2026)
  13. 10.4.3 Asia Gamma Delta T Cell Cancer Therapy Market Size by Country (2027-2032)
  14. 10.4.4 Asia Gamma Delta T Cell Cancer Therapy Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Gamma Delta T Cell Cancer Therapy Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Gamma Delta T Cell Cancer Therapy Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Gamma Delta T Cell Cancer Therapy Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Gamma Delta T Cell Cancer Therapy Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Gamma Delta T Cell Cancer Therapy Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Gamma Delta T Cell Cancer Therapy Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Gamma Delta T Cell Cancer Therapy Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Gamma Delta T Cell Cancer Therapy Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Gamma Delta T Cell Cancer Therapy Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Gamma Delta T Cell Cancer Therapy Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Gamma Delta T Cell Cancer Therapy Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Gamma Delta T Cell Cancer Therapy Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Gamma Delta T Cell Cancer Therapy Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Gamma Delta T Cell Cancer Therapy Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst